Differential diagnosis of homer worth’s rossets

Reading File
Finding Sources
Searching the Web

Homer Wright rosettes differential diagnosis pathology tumors

Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Finding Sources
Now I have comprehensive information. Let me compile the full answer.

Note on terminology: The correct eponym is Homer-Wright rosettes (named after pathologist James Homer Wright, 1869-1928). There is no eponym called "Homer Worth's rosettes." This appears to be a slight misspelling/mispronunciation.

Homer-Wright Rosettes - Overview

Homer-Wright rosettes (also called Homer-Wright pseudorosettes) are a histological pattern in which small, round blue tumor cells palisade concentrically around a central fibrillary core of neuropil - importantly, there is no central lumen (this distinguishes them from true rosettes such as Flexner-Wintersteiner rosettes).
The central core is composed of eosinophilic, fibrillary neuritic processes, reflecting neuronal differentiation of the tumor cells.
Neuroblastoma with Homer-Wright pseudorosettes - small round blue cells palisading around central fibrillary neuropil
Typical neuroblastoma showing small round blue cell features and Homer-Wright pseudorosettes (Mulholland & Greenfield's Surgery, 7e)

Differential Diagnosis: Tumors Showing Homer-Wright Rosettes

The presence of Homer-Wright rosettes narrows the differential to neuroblastic/neuroectodermal tumors, but several entities can show this pattern:

1. Neuroblastoma (Prototype/Classic)

  • Most strongly associated with Homer-Wright pseudorosettes
  • Arises from neural crest cells of the sympathetic ganglia and adrenal medulla
  • Small, round blue cells with hyperchromatic nuclei and scant cytoplasm
  • Cells palisade around central neuritic processes (neuropil)
  • IHC: NSE+, synaptophysin+, chromogranin+, NB84+, tyrosine hydroxylase+; MIC-2 (CD99) negative
  • Catecholamine metabolites (VMA/HVA) elevated in serum/urine
  • Source: Robbins, Cotran & Kumar Pathologic Basis of Disease; Mulholland & Greenfield's Surgery, 7e

2. Medulloblastoma

  • Most common malignant brain tumor of childhood (~20% of pediatric CNS tumors)
  • Arises in the posterior fossa (cerebellar vermis)
  • Highly cellular tumor with dark-staining, round, hyperchromatic nuclei; scant cytoplasm
  • Forms Homer-Wright rosettes + expresses neuronal markers (synaptophysin+); GFAP less common
  • Four WHO molecular subgroups: WNT-activated, SHH-activated, Group 3, Group 4
  • Source: Harrison's Principles of Internal Medicine 22E; Robbins, Cotran & Kumar

3. Esthesioneuroblastoma (Olfactory Neuroblastoma)

  • Accounts for 5% of sinonasal malignancies; arises in the olfactory groove
  • Characterized by both Homer-Wright pseudorosettes (no lumen) and Flexner-Wintersteiner rosettes (true, with lumen)
  • Small blue cells with lobular architecture and prominent microvascularity
  • IHC: S-100 protein+, NSE+; cytokeratin negative
  • Source: KJ Lee's Essential Otolaryngology; Scott-Brown's Otorhinolaryngology

4. Primitive Neuroectodermal Tumor (PNET) / Peripheral PNET

  • Shares major histopathologic features with neuroblastoma
  • Sheets of small round cells that may form Homer-Wright rosettes
  • Key differentiator from neuroblastoma: MIC-2 (CD99) positive in PNET, negative in neuroblastoma
  • t(12;22)(q24;q12) translocation highly specific for PNET (helps distinguish from neuroblastoma)
  • Source: Dermatology 2-Volume Set 5e; Henry's Clinical Diagnosis; Campbell-Walsh Urology

5. Pineoblastoma

  • Highly malignant pineal region tumor; primitive embryonal appearance
  • Can show Homer-Wright rosettes (and also Flexner-Wintersteiner rosettes in some cases)
  • WHO Grade 4; associated with bilateral retinoblastoma ("trilateral retinoblastoma")

6. Merkel Cell Carcinoma (MCC)

  • Primary cutaneous neuroendocrine carcinoma
  • May show rosette-like structures resembling Homer-Wright rosettes of neuroblastoma
  • IHC: CK20+, synaptophysin+, chromogranin+ (key marker - paranuclear dot pattern of CK20)
  • Source: Dermatology 2-Volume Set 5e

7. Ewing Sarcoma / Ewing Sarcoma Family Tumors (ESFTs)

  • Histologically: sheets of small round cells that may form Homer-Wright rosettes
  • ESFT subclassified into Ewing sarcoma or peripheral primitive neuroectodermal tumor
  • Key genetic marker: t(11;22)(q24;q12) - EWSR1::FLI1 fusion (most common); CD99 strongly positive
  • Source: Henry's Clinical Diagnosis; Robbins, Cotran & Kumar

8. Cutaneous Metastatic Neuroblastoma

  • In children: blue-purple dermal papules ("blueberry muffin" pattern)
  • Ill-defined infiltrative mass in dermis/subcutis with Homer Wright-type rosette formation
  • Fibrillary center is the histologic hallmark
  • Source: Dermatology 2-Volume Set 5e

9. Metastatic Malignant Melanoma (rare mimicker)

  • Rare but documented - metastatic melanoma can occasionally form Homer-Wright rosettes, mimicking a neuroblastic tumor
  • IHC differentiates: S-100+, HMB-45+, Melan-A+ in melanoma; neuronal markers absent
  • Source: PubMed PMID 12783323

Key Distinguishing Features at a Glance

TumorLocationKey IHC/GeneticsOther Rosettes
NeuroblastomaAdrenal/sympathetic gangliaNSE+, NB84+, VMA/HVA↑, MIC-2-None
MedulloblastomaPosterior fossa (cerebellum)Synaptophysin+, GFAP±, WNT/SHH subtypesNone typical
EsthesioneuroblastomaOlfactory grooveS-100+, NSE+, CK-Flexner-Wintersteiner also present
PNETPeripheral/CNSMIC-2 (CD99)+, t(12;22)None
PineoblastomaPineal glandSynaptophysin+, GFAP-Flexner-Wintersteiner possible
Merkel Cell CarcinomaSkinCK20+ (paranuclear dot), CD56+Rosette-like only
Ewing SarcomaBone/soft tissueCD99 strong+, t(11;22) EWSR1::FLI1None

Important Distinction: Homer-Wright vs. Flexner-Wintersteiner Rosettes

FeatureHomer-WrightFlexner-Wintersteiner
Central lumenAbsent (pseudorosette)Present (true rosette)
Center contentFibrillary neuropilEmpty lumen
Classic tumorNeuroblastoma, medulloblastomaRetinoblastoma
Differentiation impliesNeuronal (neuropil)Photoreceptor (retinal)
The bottom line: Homer-Wright rosettes are a marker of neuroblastic/neuronal differentiation and their presence should prompt consideration of neuroblastic tumors first, then broader small round blue cell tumors with neural features. IHC (NSE, synaptophysin, NB84, CD99, S-100, CK20) and molecular studies (MYCN amplification, characteristic translocations) are essential to narrow the differential.
This is a shared conversation. Sign in to Orris to start your own chat.